Composition and method for treating prostate cancer

Details Composition and method for treating prostate cancer Composition and method for treating prostate cancer

A - Human Necessities

61

K

A61K 31/35 (2006.01) A61K 31/352 (2006.01) A61K 47/10 (2006.01) G01N 33/53 (2006.01)

Patent

CA 2183015

Prostate cancer is treated in a patient by administration of Rhodamine-123 (Rh-123) orally or by intravenous injection of a treatment solution of Rh-123, ethyl alcohol, dextrose, and water in an amount sufficient to effect in vivo destruction of prostate cancer cells. The treatment solution is made by mixing a stock solution of Rh-123 in a solution of 95%ethyl alcohol and 5% water (by volume) with a solution of 5% (by weight) dextrose in water. Treatment is controlled by measuring the level of prostate-specific antigen (PSA) in the blood of the patient.

Affiliated with

Also associated with

Rating

Composition and method for treating prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for treating prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treating prostate cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1986376